Local Stocks
Energy Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Omeros Corp (NQ: OMER)
13.95 USD  -0.73 (-4.97%)
Official Closing Price  /  Updated: 5:57 PM EST, Feb 21, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 721,100
Open 14.70
Bid (Size) 13.50 (20)
Ask (Size) 14.75 (3)
Prev. Close 14.68
Today's Range 13.82 - 14.88
52wk Range 8.360 - 27.00
Shares Outstanding 48,292,608
Dividend Yield N/A
Performance
YTD
+17.72%
+17.72%
1 Month
+5.05%
+5.05%
3 Month
-1.83%
-1.83%
6 Month
-34.97%
-34.97%
1 Year
+32.10%
+32.10%
Top News
More News
Omeros Corporation Announces USAN and INN Selection of Nonproprietary Name for OMS721
Omeros Corporation (Nasdaq: OMER) today announced that, as the company prepares for planned commercialization of OMS721, the United States Adopted Names (USAN) Council, in consultation with the World... Read More
from Business Wire News Releases
Omeros Corporation Streamlines Path to Biologics License Application for OMS721 in HSCT-TMA Following Meeting with FDA
Omeros Corporation (Nasdaq: OMER) today announced that, based on a recent meeting with the U.S. Food and Drug Administration (FDA), the company has streamlined the required work and further advanced... Read More
from Business Wire News Releases
More News
Read More
Omeros Corporation Appoints Thomas F. Bumol, Ph.D., to Board of Directors
from Business Wire News Releases
Omeros Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy
from Business Wire News Releases
Omeros Corporation Announces Record High Quarterly Revenue Results for the Fourth Quarter 2018
from Business Wire News Releases
Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Parts, Bruker, Omeros, and Aimmune Therapeutics — Discovering Underlying Factors of Influence
from GlobeNewswire News Releases
Notable Thursday Option Activity: OMER, DLR, OSTK
category Stocks
from Market News Video
Why Omeros Stock Jumped Today
category OMER , Market News
from Motley Fool
Omeros Corp Shares Down 27.4% Since SmarTrend's Sell Call (OMER)
from Comtex SmarTrend® News Briefs
Omeros Finalizes Clinical Plan For Kidney Disease Treatment, Reports Additional Positive Phase 2 Data
category Trading Ideas , News , FDA , and 4 more.
from Benzinga
Omeros Corp Down 26.1% Since SmarTrend Downtrend Call (OMER)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.